Is Surgery in Autoimmune Pancreatitis Always a Failure?
Hana ZavrtanikAles TomazicPublished in: Medicina (Kaunas, Lithuania) (2023)
Autoimmune pancreatitis is a rare form of chronic pancreatitis of presumed autoimmune etiology. Due to significant overlap in clinical and imaging characteristics, misdiagnosis as a pancreatic malignancy is common. As a result, a significant number of patients undergo a major pancreatic resection, associated with considerable morbidity, for a disease process that generally responds well to corticosteroid therapy. In the past ten years, important advances have been made in understanding the disease. Several diagnostic criteria have been developed to aid in diagnosis. Despite this, pancreatic resection may still be required in a subset of patients to reliably exclude pancreatic malignancy and establish a definite diagnosis of autoimmune pancreatitis. This article aimed to define the role of surgery in autoimmune pancreatitis, if any. For this purpose, published case series of patients with a diagnosis of autoimmune pancreatitis, based on the histopathological examination of surgical specimens, were reviewed and patients' clinical, radiological and serological details were assessed. At the end, histopathologic examinations of patients who underwent pancreatic resection at our department in the last 10 years were retrospectively reviewed in order to identify patients with autoimmune pancreatitis and assess their clinical characteristics.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- multiple sclerosis
- newly diagnosed
- prognostic factors
- systematic review
- stem cells
- randomized controlled trial
- minimally invasive
- high resolution
- mesenchymal stem cells
- coronary artery disease
- mass spectrometry
- coronary artery bypass
- patient reported
- percutaneous coronary intervention